CUPE - Winter2027 - TA - LAB 130HR - BCH2733

Posting Reason:
New Position
Location where work is to be performed:
Main Campus
Session:
2027 Winter Semester | Trimestre d'hiver
Faculty:
Faculté des sciences / Faculty of Science
Unit:
Department of Chemistry and Biomolecular Sciences, Students & Casuals
Job Classification:
Teaching Assistant/Demonstrator/Lab Monitor (CUPE)
Posting Type:
Cours précis / Specific course
Course Title:
Introduction à la Biochimie
Course Code:
BCH2733
Section:
LABORATOIRE
Supervisor name (if known):

Josée Coutu / Luc Poitras
Date Posted (YYYY/MM/DD):
2026/10/05
Applications must be received BEFORE (YYYY/MM/DD):
2026/10/20
Description of tasks (hours):
Unless specified below, specific allocation of hours to various tasks should be articulated in a description of work negotiated and signed by you and the supervising professor prior to the commencement of work.
Recherche / Research:0

Préparation / Preparation:0

Contact avec étudiants / Contact with Students:44

Correction - Notation / Grading:76

Surveillance / Proctoring:4

Formation / Training:6

Autre / Other:0
Number of positions:
15
Expected Enrolment:
225
Work Start Date:
January 01, 2027
Work End Date:
April 30, 2027
Total Work Hours:
130
Hourly Rate:
AE-RA-Tuteur / TA-RA-Tutor : $33.83 ou/or $53.31 (Sept. 2026 - Aug. 2027)
Undergraduate students will be paid at the lower rate; while graduate students will be paid at the higher rate.

These rates do not include vacation pay nor statutory pay.

Method of Delivery:
In person
Language of Work:
Français | French

Requirements and Nature of Work:
Position Summary
As a Laboratory Demonstrator, you will be responsible for supervising laboratory sessions during which you will deliver short instructional presentations and evaluate student performance. Duties also include grading laboratory reports for all assigned sections, as well as overseeing the introductory laboratory sessions held during the first week of the course. Additionally, you will be expected to respond to student inquiries via email and ensure the implementation of all laboratory safety protocols.
Minimum Qualifications
Bachelor’s degree in Biochemistry or a related field

Practical knowledge of standard biochemical techniques

Completion of training on the Workplace Hazardous Materials Information System (WHMIS) and the Occupational Health and Safety Act (OHSA)

Reading proficiency in English is considered an asset

Additional Information and/or Comments:

All University of Ottawa employees are required under provincial law to successfully complete all mandatory legislated training offered by the University. The list of training requirements may be modified by provincial law. If you are invited to continue the selection process, please notify us of any particular adaptive measures you might require. We may consult with the Health and Wellness sector of Human Resources, if needed. Any information you send us will be handled respectfully and in complete confidence.

The hiring process will be governed by the current CUPE 2626 collective agreement; you can click here to find out more.

The University of Ottawa embraces diversity and inclusion in the workplace. We are passionate about our people and committed to employment equity. We foster a culture of respect, teamwork and inclusion, where collaboration, innovation, and creativity fuel our quest for research and teaching excellence. While all qualified persons are invited to apply, we welcome applications from qualified Indigenous persons, racialized persons, persons with disabilities, women and LGBTQIA2S+ persons. The University is committed to creating and maintaining an accessible, barrier-free work environment. The University is also committed to working with applicants with disabilities requesting accommodation during the recruitment, assessment and selection processes. Applicants with disabilities may contact the academic unit to communicate the accommodation need.

Prior to May 1, 2022, the University required all students, faculty, staff, and visitors (including contractors) to be fully vaccinated against Covid-19 as defined in Policy 129 – Covid-19 Vaccination. This policy was suspended effective May 1, 2022 but may be reinstated at any point in the future depending on public health guidelines and the recommendations of experts.